The EPS projection of Thermo Fisher Scientific Inc (NYSE:TMO) for period quarter completed 2016-12-31 is $2.37.
The EPS estimates pronounced a week and 30 days ago were $2.37 and $2.37 correspondingly. The EPS forecasts specified 60 and 90 days before were $2.37 and $2.37 respectively. From a week ago, the aberration in EPS forecast is 0 percent.
The mean EPS prediction straightaway before the earnings release for the quarter completed 2 is $2.37 based on 10 EPS estimations. The EPS stated on 2016-07-28 was $2.03. The EPS surprise was $0.03, or 1.5 percent. The standard deviation as per known EPS estimates was $0.04.
The positive EPS revisions were 0 a week earlier and negative revisions were 0. In last 30 and 60 days, the positive EPS revisions were 2 and 3 correspondingly, while for 90 and 120 days, revisions count was 6 and 6.
The negative revisions of per-share earnings in the last 30 and 60-days were 0 and 0 in that order. however, for 90 and 120 days’ period, the count was 0 and 0 in that order.
EPS revisions upgrade and downgrade in the last 18 days were 6 and 0 correspondingly.
Quarterly Sales Estimates
The arithmetic mean of probable annual sales of Thermo Fisher Scientific Inc (NYSE:TMO) is $4963.25 and the median was $4963.25. The estimate is stated by 2 analysts for the fiscal 2017.
The highest annual projection is $5030 and lowest sales target is $4896.5. This marks a standard deviation of $94.398.
Almost 2 have given revised positive sales forecast in the past week and 2 have downgraded forecasts. As per the stated estimates, the change in target from the past week is 0 percent.
Nearly 2 have revised sales projections in positive side over the past month and 2 have downgraded forecasts. This shows a mean estimate deviation of 0 percent.
Just about 2 have revised sales forecast on plus side over the quarter and 2 have downgraded forecasts. This shows mean estimate deviation of -0.423 percent.
1 Chart Pattern Every Investor Should Know